Sorry to hear that.
Very interesting with a strategy to look at using Eugenie to keep relationship with health providers.
Having to use Distributers to get the Eugenie out there.
Short termism for health providers who will move to a better test once they have used up existing tests.
Just had a slide highlighting current Lateral flow value - $7Bil per annum - If with a gold standard test we achieve only 1% of that and with a PE of 30, we would look at a market cap of 2.1Bil.
To grow by 2026 to more than 3 fold of that.
I am happy with my holding and I am quite optimistic.
Sorry to hear that.Very interesting with a strategy to look at...
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.2¢ |
Change
-0.001(4.35%) |
Mkt cap ! $54.30M | |||
| Open | High | Low | Value | Volume |
| 2.2¢ | 2.3¢ | 2.2¢ | $10.68K | 485.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 799999 | 2.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.3¢ | 484813 | 4 |
View Market Depth
| Last trade - 16.10pm 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
2.3¢ |
Change
-0.001 ( 1.32 %) |
||||
| Open | High | Low | Volume | ||
| 2.2¢ | 2.3¢ | 2.2¢ | 701410 | ||
| Last updated 15.59pm 07/06/2024 ? | |||||
| ADO (ASX) Chart |